Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy 
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle 
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power 
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms 
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring 
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube 
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025 
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital 
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions 
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares 
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch 
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts 
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 
Dublin, March 03, 2017 -- Research and Markets has announced the addition of the "Global Liquid Biopsy Market Analysis 2016 - Forecast to 2022" report to their offering.
Annual estimations and forecasts are provided from the year 2013 to 2022 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends.
Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities.
This analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis.
The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments.
Scope of the Report
Disease Indication
- Breast Cancer
- Gastrointestinal Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Leukemia
Biomarker
- Exosomes
- Circulating Tumor DNA (ctDNA)
- Circulating Tumor Cells (CTC)
- Single Gene Analysis (PCR Microarrays)
- Multi - gene - parallel Analysis (NGS)
Sample Type
- Urine Sample based
- Blood Sample based
- Saliva
- Tissue fluids
Application
- Molecular Health Monitoring
- Therapy Selection for Metastatic Breast Cancer (MBS)
- Therapy Selection for Other Metastatic Cancer
Company Profiles
- Internap Corporation
- CDN Networks
- Tata Communications
- Level 3 Communications
- Google Inc.
- Limelight Networks, Inc.
- Highwinds Network Group, Inc.
- Akamai Technologies, Inc.
- Verizon Communications, Inc.
- Amazon Web Services, Inc.
- CloudFlare, Inc.
- Orange S.A.
- MaxCDN Enterprise
- Ericssion
- AT&T Inc.
For more information about this report visit http://www.researchandmarkets.com/research/wtw4hh/global_liquid
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: In Vitro Diagnostics
